FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Jewett

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Ashraf Almatar; Michael A S Jewett
Small renal masses: Time to standardize follow-up of low-stage renal cancer.
Heba W Z Khella; Zsuzsanna Lichner; Alexander D Romaschin; Marize Bakhet; Michael A S Jewett; George M Yousef
MicroRNAs in Kidney Disease: An Emerging Understanding.
Nathan Perlis; Polat Turker; Peter J Bostrom; Antonio Finelli; Neil E Fleshner; Michael A S Jewett; Cynthia Kuk; Girish Kulkarni; Tuomas Mirtti; Alexandre R Zlotta
Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Jewett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ashraf Almatar; Michael A S Jewett
Small renal masses: Time to standardize follow-up of low-stage renal cancer.
Nature reviews. Urology 2013;10(5):257-9.
2013: Heba W Z Khella; Zsuzsanna Lichner; Alexander D Romaschin; Marize Bakhet; Michael A S Jewett; George M Yousef
MicroRNAs in Kidney Disease: An Emerging Understanding.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2013;61(5):798-808.
2013: Nathan Perlis; Polat Turker; Peter J Bostrom; Antonio Finelli; Neil E Fleshner; Michael A S Jewett; Cynthia Kuk; Girish Kulkarni; Tuomas Mirtti; Alexandre R Zlotta
Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols.
World journal of urology 2013;31(1):161-7.
2012: Mark Kowalski; Celine Moore; Louise Brazas; Jeannick Cizeau; Joycelyn Entwistle; Jacinthe Guindon; Michael A S Jewett; Glen C MacDonald
A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guérin.
The Journal of urology 2012;188(5):1712-8.
2012: Jacqueline L Bender; Peter Chung; Philippe L Bedard; Michael A S Jewett; Andrew Matthew; Malcolm Moore; Matthew J To; Padraig Warde; David Wiljer; Mary Gospodarowicz
Testicular cancer survivors' supportive care needs and use of online support: a cross-sectional survey.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(11):2737-46.
2012: Bas W G van Rhijn; André N Vis; Tahlita C M Zuiverloon; Ellen C Zwarthoff; Sultan S Alkhateeb; Chris H Bangma; Bharati Bapat; Peter J Bostrom; Neil E Fleshner; Michael A S Jewett; Liyang Liu; Madelon N M van der Aa; Theo H van der Kwast; Alexandre R Zlotta
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
BJU international 2012;110(8):1169-76.
2012: David Bowes; Juanita M Crook; Andrew Evans; Antonio Finelli; Neil Fleshner; Michael A S Jewett; Ants Toi; Kris Wallace; Charles Catton
Results of a surgically derived nomogram to predict Gleason score upgrading applied to a cohort of patients with "favorable-risk" prostate cancer treated with permanent seed brachytherapy.
Urology 2012;80(3):649-55.
2012: Alessandro Volpe; Antonio Finelli; Inderbir S Gill; Michael A S Jewett; Guido Martignoni; Thomas J Polascik; Mesut Remzi; Robert G Uzzo
Rationale for percutaneous biopsy and histologic characterisation of renal tumours.
European urology 2012;62(3):491-504.
2012: Jacqueline L Bender; Christina M Canil; Laura Legere; Andrew Loblaw; Andrew Matthew; David Wiljer; Michael A S Jewett
Fostering partnerships in survivorship care: report of the 2011 Canadian genitourinary cancers survivorship conference.
Journal of cancer survivorship : research and practice 2012;6(3):296-304.
2012: Hala Faragalla; Michael A S Jewett; Bishoy Khalil; Heba Khella; Zsuzsanna Lichner; Mejia-Guerrero Salvador; Andreas Scorilas; Linda Sugar; Nicole M A White; Magdy I Attalah; Georg Bjarnason; Andrew Evans; Youssef M Youssef; George M Yousef
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
The Journal of molecular diagnostics : JMD 2012;14(4):385-92.
2012: Darryl N Hoffer; Raymond Chow; Antonio Finelli; Brenda Gallie; Jennifer J Knox; Ghada Kurban; Kelly Lane; Laura Legere; Justin Liu; Sanoj Punnen; Tran Truong; Michael A S Jewett
Structured electronic operative reporting: comparison with dictation in kidney cancer surgery.
International journal of medical informatics 2012;81(3):182-91.
2012: Ghada Kurban; Michael Leveridge; Donco Matevski; Diane Rushlow; Andrew Evans; Antonio Finelli; Brenda L Gallie; Rashi Gupta; Michael A S Jewett
Needle core biopsies provide ample material for genomic and proteomic studies of kidney cancer: observations on DNA, RNA, protein extractions and VHL mutation detection.
Pathology, research and practice 2012;208(1):22-31.
2011: Siamak Daneshmand; Joel Sheinfeld; Andrew J Stephenson; Michael A S Jewett
The management of subcentimeter residual mass in NSGCT: pcRPLND vs. observation.
Urologic oncology 2011;29(6):842-7.
2011: Peter J Bostrom; Anjum Chagpar; Raymond Chow; Antonio Finelli; Neil E Fleshner; Ethan D Grober; Kelly Lane; Laura Legere; Justin Liu; Paul J Toren; Tran Truong; Hao Xi; Alexandre R Zlotta; Michael A S Jewett
Point-of-care clinical documentation: assessment of a bladder cancer informatics tool (eCancerCareBladder): a randomized controlled study of efficacy, efficiency and user friendliness compared with standard electronic medical records.
Journal of the American Medical Informatics Association : JAMIA 2011;18(6):835-41.
2011: David Wiljer; Michael A S Jewett; Jacqueline L Bender
A Call to Arms: moving forward from "Fostering the Partnership" Canadian GU Cancers Survivorship Conference 2011.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2011;5(5):323.
2011: Alan Horwich; Jörg Beyer; Gedske Daugaard; Christian Kollmannsberger; Michael A S Jewett
Salvage therapy: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Urology 2011;78(4 Suppl):S469-74.
2011: Sarah Kawaguchi; Michael Robinette; Kimberly A Fernandes; Antonio Finelli; Neil Fleshner; Michael A S Jewett
Most renal oncocytomas appear to grow: observations of tumor kinetics with active surveillance.
The Journal of urology 2011;186(4):1218-22.
2011: Hein Van Poppel; Frank Becker; Jeffrey A Cadeddu; Inderbir S Gill; Gunther Janetschek; Michael A S Jewett; M Pilar Laguna; Michael Marberger; Francesco Montorsi; Thomas J Polascik; Osamu Ukimura; Gang Zhu
Treatment of localised renal cell carcinoma.
European urology 2011;60(4):662-72.
2011: Michael A S Jewett; Kamal Mattar; Joan Basiuk; Christopher G Morash; Stephen E Pautler; D Robert Siemens; Simon Tanguay; Ricardo A Rendon; Martin E Gleave; Darrel E Drachenberg; Raymond Chow; Hannah Chung; Joseph L Chin; Neil E Fleshner; Andrew J Evans; Brenda L Gallie; Masoom A Haider; John R Kachura; Ghada Kurban; Kimberly Fernandes; Antonio Finelli
Active surveillance of small renal masses: progression patterns of early stage kidney cancer.
European urology 2011;60(1):39-44.
2011: Michael J Leveridge; Michael A S Jewett
Recent developments in kidney cancer.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2011;5(3):195-203.
2011: Oleksandr Stakhovskyi; Stanley A Yap; Michael Leveridge; Nathan Lawrentchuk; Nathan Lawrentschuk; Michael A S Jewett
Small renal mass: what the urologist needs to know for treatment planning and assessment of treatment results.
AJR. American journal of roentgenology 2011;196(6):1267-73.
2011: Alexandre R Zlotta; Thierry Roumeguere; Cynthia Kuk; Sultan Alkhateeb; Sandrine Rorive; Anne Lemy; Theodorus H van der Kwast; Neil E Fleshner; Michael A S Jewett; Antonio Finelli; Claude Schulman; Yair Lotan; Shahrokh F Shariat; Joelle Nortier
Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer.
European urology 2011;59(6):1026-31.
2011: Michael A S Jewett
Words of wisdom. Re: management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery.
European urology 2011;59(5):880-1.
2011: Ross J Mason; Mohamed Abdolell; Greg Trottier; Christopher Pringle; Joseph G Lawen; David G Bell; Michael A S Jewett; Laurence Klotz; Ricardo A Rendon
Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
European urology 2011;59(5):863-7.
2011: Mohamed Abdelgawad; Chun Wu; Wei-Yin Chien; William Geddie; Michael A S Jewett; Yu Sun
A fast and simple method to fabricate circular microchannels in polydimethylsiloxane (PDMS).
Lab on a chip 2011;11(3):545-51.
2011: David M Kakiashvili; Bas W G van Rhijn; Greg Trottier; Michael A S Jewett; Neil Fleshner; Antonio Finelli; Julian Azuero; Chris H Bangma; Rati Vajpeyi; Sultan Alkhateeb; Sally Hanna; Alex Kostynsky; Cynthia Kuk; Theodorus H Van Der Kwast; Alexandre R Zlotta
Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment.
BJU international 2011;107(4):540-6.
2011: Nathan Lawrentschuk; Alvaro Zuniga; Arthur C Grabowksi; Ricardo A Rendon; Michael A S Jewett
Partial orchiectomy for presumed malignancy in patients with a solitary testis due to a prior germ cell tumor: a large North American experience.
The Journal of urology 2011;185(2):508-13.
2011: Jian Chen; Yi Zheng; Qingyuan Tan; Yan Liang Zhang; Jason Li; William Geddie; Michael A S Jewett; Yu Sun
A microfluidic device for simultaneous electrical and mechanical measurements on single cells.
Biomicrofluidics 2011;5(1):14113.
2010: Michael A S Jewett
Can tumour location predict degree of malignancy in small renal masses?
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2010;4(6):418.
2010: Alvaro Zuniga; Nathan Lawrentschuk; Michael A S Jewett
Organ-sparing approaches for testicular masses.
Nature reviews. Urology 2010;7(8):454-64.
2010: Frederik C Roos; Andrew M Roberts; Irene I L Hwang; Eduardo H Moriyama; Andrew J Evans; Stephanie Sybingco; Ian R Watson; Leticia A M Carneiro; Craig Gedye; Stephen E Girardin; Laurie E Ailles; Michael A S Jewett; Michael Milosevic; Brian C Wilson; John C Bell; Sandy D Der; Michael Ohh
Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus.
EMBO molecular medicine 2010;2(7):275-88.
2010: Sultan S Alkhateeb; Bas W G van Rhijn; Antonio Finelli; Theodorus van der Kwast; Andrew Evans; Sally Hanna; Rati Vajpeyi; Neil Fleshner; Michael A S Jewett; Alexandre R Zlotta
Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
The Journal of urology 2010;184(1):81-6.
2010: Bas W G van Rhijn; Theo Van der Kwast; David M Kakiashvili; Neil Fleshner; Madelon N M van der Aa; Sultan Alkhateeb; Chris H Bangma; Michael A S Jewett; Alexandre R Zlotta
Pathological stage review is indicated in primary pT1 bladder cancer.
BJU international 2010;106(2):206-11.
2010: Michael J Leveridge; Kamal Mattar; John Kachura; Michael A S Jewett
Assessing outcomes in probe ablative therapies for small renal masses.
Journal of endourology / Endourological Society 2010;24(5):759-64.
2010: Alexandre R Zlotta; Samuel M Cohen; Colin Dinney; Michael Droller; Theo Van der Kwast; Bas W G van Rhijn; Bernard H Bochner; Gilad Ameil; Michael A S Jewett
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancer.
Urologic oncology 2010;28(3):329-33.
2010: Shaun Tolan; Danny Vesprini; Michael A S Jewett; Padraig R Warde; Martin O'Malley; Tony Panzarella; Jeremy F G Sturgeon; Malcolm Moore; Betty Tew-George; Mary K Gospodarowicz; Peter W M Chung
No role for routine chest radiography in stage I seminoma surveillance.
European urology 2010;57(3):474-9.
2010: Inderbir S Gill; Monish Aron; Debra A Gervais; Michael A S Jewett
Clinical practice. Small renal mass.
The New England journal of medicine 2010;362(7):624-34.
2009: Girish S Kulkarni; Shabbir M H Alibhai; Antonio Finelli; Neil Fleshner; Michael A S Jewett; Steven R Lopushinsky; Ahmed M Bayoumi
Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer.
Cancer 2009;115(23):5450-9.
2009: Michael Ordon; Scott Boerner; Alexandre R Zlotta; Michael A S Jewett; Neil Fleshner
The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma.
BJU international 2009;104(11):1641-5.
2009: Alvaro Zuniga; David Kakiashvili; Michael A S Jewett
Surveillance in stage I nonseminomatous germ cell tumours of the testis.
BJU international 2009;104(9 Pt B):1351-6.
2009: David Michael Kakiashvili; Alvaro Zuniga; Michael A S Jewett
High risk NSGCT: case for surveillance.
World journal of urology 2009;27(4):441-7.
2009: Ryan J Groll; Kevin J Leonard; Joan Eakin; Padraig Warde; Jackie Bender; Michael A S Jewett
Electronic surveillance of testicular cancer: understanding patient perspectives on access to electronic medical records.
Journal of oncology practice / American Society of Clinical Oncology 2009;5(4):177-81.
2009: Alessandro Volpe; Michael A S Jewett
Current role, techniques and outcomes of percutaneous biopsy of renal tumors.
Expert review of anticancer therapy 2009;9(6):773-83.
2009: Phuong L Mai; Bingshu E Chen; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Istvan Bodrogi; Lajos Geczi; Edith Olah; Ketil Heimdal; Sophie D Fosså; Katherine L Nathanson; Larissa Korde; Douglas F Easton; Darshna Dudakia; Robert Huddart; Michael R Stratton; D Timothy Bishop; Elizabeth A Rapley; Mark H Greene
Younger age-at-diagnosis for familial malignant testicular germ cell tumor.
Familial cancer 2009;8(4):451-6.
2008: Alessandro Volpe; Kamal Mattar; Antonio Finelli; John R Kachura; Andrew J Evans; William Geddie; Michael A S Jewett
Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience.
The Journal of urology 2008;180(6):2333-7.
2008: Michael A S Jewett; Alvaro Zuniga
Renal tumor natural history: the rationale and role for active surveillance.
The Urologic clinics of North America 2008;35(4):627-34; vii.
2008: Michael J Leveridge; Michael A S Jewett
Which urinary diversion is best after radical cystectomy? The case for "incontinent" diversion.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2008;2(4):410-1.
2008: Girish S Kulkarni; Antonio Finelli; Gina Lockwood; Arthy Saravanan; Andrew Evans; Michael A S Jewett; John Trachtenberg; Michael Robinette; Neil E Fleshner
Effect of healthcare provider characteristics on nodal yield at radical cystectomy.
Urology 2008;72(1):128-32.
2008: Stéphane Supiot; Shubber Shubbar; Neil Fleshner; Padraig Warde; Karen Hersey; Kris Wallace; Heather Cole; Joan Sweet; John Tsihlias; Michael A S Jewett; Laurence Klotz; Robert G Bristow
A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;88(1):53-60.
2008: Mischel G Neill; Michael A S Jewett
The once and future role of cytoreductive nephrectomy.
Urologic oncology 2008;26(4):346-52.
2008: Michael A S Jewett; Jennifer J Knox; Christian Kollmansberger; Joan Basiuk
Canadian kidney cancer forum 2008.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2008;2(3):183.
2008: Michael A S Jewett; Alvaro Zuniga
Who will fail local therapy for renal cell carcinoma.
The Journal of urology 2008;179(6):2087-8.
2008: Ethan D Grober; Dean S Elterman; Michael A S Jewett
Fellow or foe: the impact of fellowship training programs on the education of Canadian urology residents.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2008;2(1):33-7.
2008: Kamal Mattar; Michael A S Jewett
Watchful waiting for small renal masses.
Current urology reports 2008;9(1):22-5.
2008: Robert K Nam; William W Zhang; D Andrew Loblaw; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; A Stanimirovic; T O Davies; Ants Toi; Vasundara Venkateswaran; Linda Sugar; Katherine A Siminovitch; Steven A Narod
A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.
Prostate cancer and prostatic diseases 2008;11(3):241-6.
2007: Michelle L Gervais; Pauline C Henry; Arthy Saravanan; T Nadine Burry; Brenda L Gallie; Michael A S Jewett; Richard P Hill; Andrew J Evans; Michael Ohh
Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2007;87(12):1252-64.
2007: Girish S Kulkarni; Antonio Finelli; Neil Fleshner; Michael A S Jewett; Steven R Lopushinsky; Shabbir M H Alibhai
Optimal management of high-risk T1G3 bladder cancer: a decision analysis.
PLoS medicine 2007;4(9):e284.
2007: Robert K Nam; Ants Toi; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; Sree Appu; D Andrew Loblaw; Linda Sugar; Steven A Narod; Michael W Kattan
Assessing individual risk for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3582-8.
2007: Alessandro Volpe; John R Kachura; William Geddie; Andrew J Evans; Arash Gharajeh; Arthy Saravanan; Michael A S Jewett
Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy.
The Journal of urology 2007;178(2):379-86.
2007: Mischel G Neill; Alice C Wei; Michael A S Jewett
Consolidative renal cell carcinoma metastatectomy for partial response after multitargeted tyrosine kinase inhibitor therapy.
Urology 2007;70(1):178.e9-11.
2007: Mark S Soloway; Cheryl T Lee; Gary D Steinberg; Abdullah Al Ghandi; Michael A S Jewett
Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
Urologic oncology 2007;25(4):338-40.
2007: Peter W M Chung; Robert G Bristow; Michael F Milosevic; Qi-Long Yi; Michael A S Jewett; Padraig R Warde; Charles Catton; Michael McLean; Malcolm Moore; Ian F Tannock; Mary K Gospodarowicz
Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
Urologic oncology 2007;25(4):303-9.
2007: Alan M Nieder; Mark S Soloway; Michael A S Jewett
Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79.
The Journal of urology 2007;178(1):352.
2007: Michael A S Jewett; Laurence H Klotz
Advances in the medical management of benign prostatic hyperplasia.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2007;176(13):1850-1.
2007: Girish S Kulkarni; Gina Lockwood; Andrew Evans; Ants Toi; John Trachtenberg; Michael A S Jewett; Antonio Finelli; Neil Fleshner
Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
Cancer 2007;109(12):2432-8.
2007: Lori A Wood; Michael A S Jewett
Renal cell carcinoma: currently the most interesting genitourinary malignancy.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2007;1(2 Suppl):S74-6.
2007: Michael A S Jewett; Ryan J Groll
Nerve-sparing retroperitoneal lymphadenectomy.
The Urologic clinics of North America 2007;34(2):149-58; abstract viii.
2007: Alessandro Volpe; Michael A S Jewett
The role of surveillance for small renal masses.
Nature clinical practice. Urology 2007;4(1):2-3.
2007: Andrew J Evans; Ryan C Russell; olga roche; T Nadine Burry; Jason E Fish; Vinca W K Chow; William Kim; Arthy Saravanan; Mindy A Maynard; Michelle L Gervais; Roxana I Sufan; Andrew M Roberts; Leigh A Wilson; Mark Betten; Cindy Vandewalle; Geert Berx; Philip A Marsden; Meredith S. Irwin; Bin Tean Teh; Michael A S Jewett; Michael Ohh
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.
Molecular and cellular biology 2007;27(1):157-69.
2006: Sanoj Punnen; Masoom A Haider; Gina Lockwood; Fenella Moulding; Martin E O'Malley; Michael A S Jewett
Variability in size measurement of renal masses smaller than 4 cm on computerized tomography.
The Journal of urology 2006;176(6 Pt 1):2386-90; discussion 2390.
2006: Robert J Hamilton; Michael A S Jewett; Antonio Finelli
An efficient solution to the retained Foley catheter.
Urology 2006;68(5):1109-11.
2006: Robert K Nam; William W Zhang; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; Joan Sweet; Ants Toi; Seamus Teahan; Vasundara Venkateswaran; Linda Sugar; Andrew Loblaw; Katherine A Siminovitch; Steven A Narod
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(21):6452-8.
2006: Jehonathan H Pinthus; Maciej Witkos; N E Fleshner; Joan Sweet; Andrew Evans; Michael A S Jewett; Murray Krahn; Shabbir M H Alibhai; John Trachtenberg
Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome.
The Journal of urology 2006;176(3):979-84; discussion 984.
2006: Ethan D Grober; Michael A S Jewett
The concept and trajectory of "operative competence" in surgical training.
Canadian journal of surgery. Journal canadien de chirurgie 2006;49(4):238-40.
2006: Shabbir M H Alibhai; Sameera Rahman; Padraig R Warde; Michael A S Jewett; Taha Jaffer; Angela M Cheung
Prevention and management of osteoporosis in men receiving androgen deprivation therapy: a survey of urologists and radiation oncologists.
Urology 2006;68(1):126-31.
2006: Robert K Nam; Ants Toi; Laurence H Klotz; John Trachtenberg; Michael A S Jewett; Andrew Loblaw; Gregory R Pond; Marjan Emami; Linda Sugar; Joan Sweet; Steven A Narod
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
The Canadian journal of urology 2006;13 Suppl 2():2-10.
2006: Robert K Nam; Jonathan R Reeves; Ants Toi; Hélène Dulude; John Trachtenberg; Marjan Emami; Luc Daigneault; Chandra Panchal; Linda Sugar; Michael A S Jewett; Steven A Narod
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis.
The Journal of urology 2006;175(4):1291-7.
2006: Daniel Taussky; Juanita Crook; Abdullah Al Ghamdi; Neil Fleshner; Michael A S Jewett
Treatment of the inguinal regions in penile cancer: a review of the literature and treatment proposal.
The Canadian journal of urology 2006;13(1):2978-83.
2006: Peter W M Chung; Michael A S Jewett; Padraig R Warde
Testicular radiation for primary seminoma in a solitary testis.
The Canadian journal of urology 2006;13(1):2975-7.
2006: Girish S Kulkarni; Rami Al Azab; Gina Lockwood; Ants Toi; Andrew Evans; John Trachtenberg; Michael A S Jewett; Antonio Finelli; Neil Fleshner
Evidence for a biopsy derived grade artifact among larger prostate glands.
The Journal of urology 2006;175(2):505-9.
2006: Robert K Nam; Ants Toi; John Trachtenberg; Laurence H Klotz; Michael A S Jewett; Marjan Emami; Linda Sugar; Joan Sweet; Gregory R Pond; Steven A Narod
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
The Journal of urology 2006;175(2):489-94.
2006: Ricardo A Rendon; Michael A S Jewett
Expectant management for the treatment of small renal masses.
Urologic oncology 2006;24(1):62-7.
2006: Michael A S Jewett
Upper tract urothelial carcinoma.
The Journal of urology 2006;175(1):12-3.
2005: Alan M Nieder; Maurizio Brausi; Donald Lamm; Michael O'Donnell; Kyouichi Tomita; Henry Woo; Michael A S Jewett
Management of stage T1 tumors of the bladder: International Consensus Panel.
Urology 2005;66(6 Suppl 1):108-25.
2005: Robert K Nam; William W Zhang; Michael A S Jewett; John Trachtenberg; Laurence H Klotz; Marjan Emami; Linda Sugar; Joan Sweet; Ants Toi; Steven A Narod
The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8391-7.
2005: Mindy A Maynard; Andrew J Evans; Tomoko Hosomi; Shuntaro Hara; Michael A S Jewett; Michael Ohh
Human HIF-3alpha4 is a dominant-negative regulator of HIF-1 and is down-regulated in renal cell carcinoma.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(11):1396-406.
2005: Alessandro Volpe; Michael A S Jewett
The natural history of small renal masses.
Nature clinical practice. Urology 2005;2(8):384-90.
2005: Robert K Nam; John Trachtenberg; Michael A S Jewett; Ants Toi; Andrew Evans; Marjan Emami; Steven A Narod; Michael Pollak
Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(5):1270-3.
2005: Abdullah M Al Ghamdi; Michael A S Jewett
Stage I nonseminomatous germ cell tumors: the case for management by risk stratification.
The Canadian journal of urology 2005;12 Suppl 1():62-5; discussion 103-4.
2005: Joel M H Teichman; Edward Matsumoto; Michael Smart; Aspen E Smith; Wayne Tongco; Denis E Hosking; Andrew E MacNeily; Michael A S Jewett
Personal finances of residents at three Canadian universities.
Canadian journal of surgery. Journal canadien de chirurgie 2005;48(1):27-32.
2004: Robert K Nam; Ants Toi; John Trachtenberg; Michael A S Jewett; Laurence Klotz; Neil Fleshner; P Scott Bagnell; Joan Sweet; Linda Sugar; Steven A Narod
Variation in patterns of practice in diagnosing screen-detected prostate cancer.
BJU international 2004;94(9):1239-44.
2004: Michael A S Jewett
Current limitations of radiofrequency ablation in renal cell carcinoma.
Der Urologe. Ausg. A 2004;43 Suppl 3():S122-3.
2004: Roxana I Sufan; Michael A S Jewett; Michael Ohh
The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
American journal of physiology. Renal physiology 2004;287(1):F1-6.
2004: Peter W M Chung; Mary K Gospodarowicz; Tony Panzarella; Michael A S Jewett; Jeremy F G Sturgeon; Betty Tew-George; Andrew Bayley; Charles Catton; Michael F Milosevic; Malcolm Moore; Padraig R Warde
Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
European urology 2004;45(6):754-59; discussion 759-60.
2004: Bijan Shekarriz; Jyoti Upadhyay; Michael A S Jewett
Nerve-sparing retroperitoneal lymphadenectomy using hydro-jet dissection: initial experience.
Journal of endourology / Endourological Society 2004;18(3):273-6.
2004: Peter W M Chung; Andrew Bayley; Joan Sweet; Michael A S Jewett; Betty Tew-George; Mary K Gospodarowicz; Padraig R Warde
Spermatocytic seminoma: a review.
European urology 2004;45(4):495-8.
2004: Alessandro Volpe; Tony Panzarella; Ricardo A Rendon; Masoom A Haider; Filippos I Kondylis; Michael A S Jewett
The natural history of incidentally detected small renal masses.
Cancer 2004;100(4):738-45.
2004: Ethan D Grober; John Tsihlias; Michael A S Jewett; Joan Sweet; Andrew J Evans; John Trachtenberg; Mike Robinette; Robert K Nam
Correlation of the primary Gleason pattern on prostate needle biopsy with clinico-pathological factors in Gleason 7 tumors.
The Canadian journal of urology 2004;11(1):2157-62.
2004: Andrew J Evans; Brenda L Gallie; Michael A S Jewett; Gregory R Pond; Kirk Vandezande; John Underwood; Yves Fradet; Gloria Lim; Paula Marrano; Maria Zielenska; Jeremy A Squire
Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.
The American journal of pathology 2004;164(1):285-93.
2003: Robert K Nam; William W Zhang; John Trachtenberg; Michael A S Jewett; Marjan Emami; Danny Vesprini; William Chu; Minnie Ho; Joan Sweet; Andrew Evans; Ants Toi; Michael Pollak; Steven A Narod
Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(12):1429-37.
2003: Ethan D Grober; Edward D Matsumoto; Michael A S Jewett; Joseph L Chin
The Canadian Urology Fair: a model for minimizing the financial and academic costs of the residency selection process.
Canadian journal of surgery. Journal canadien de chirurgie 2003;46(6):458-62.
2003: Michael A S Jewett; Arthur Grabowski; James McKiernan
Management of recurrence and follow-up strategies for patients with nonseminoma testis cancer.
The Urologic clinics of North America 2003;30(4):819-30.
2003: Laurence H Klotz; S Larry Goldenberg; Michael A S Jewett; Y Fradet; Robert K Nam; Jack Barkin; J Chin; S Chatterjee
Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy.
The Journal of urology 2003;170(3):791-4.
2003: Mihaela Pop; Andrea Molckovsky; Lee Chin; Michael Kolios; Michael A S Jewett; Michael D Sherar
Changes in dielectric properties at 460 kHz of kidney and fat during heating: importance for radio-frequency thermal therapy.
Physics in medicine and biology 2003;48(15):2509-25.
2003: Peter W M Chung; Padraig R Warde; Tony Panzarella; Andrew Bayley; Charles Catton; Michael F Milosevic; Michael A S Jewett; Jeremy F G Sturgeon; Malcolm Moore; Mary K Gospodarowicz
Appropriate radiation volume for stage IIA/B testicular seminoma.
International journal of radiation oncology, biology, physics 2003;56(3):746-8.
2003: Robert K Nam; William W Zhang; John Trachtenberg; Eleftherios Diamandis; Ants Toi; Marjan Emami; Minnie Ho; Joan Sweet; Andrew Evans; Michael A S Jewett; Steven A Narod
Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2312-9.
2003: Robert K Nam; Michael A S Jewett; Murray D Krahn; Michael A Robinette; John Tsihlias; Ants Toi; Minnie Ho; Andrew Evans; Joan Sweet; John Trachtenberg
Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy.
The Canadian journal of urology 2003;10(3):1891-8.
2003: Antonio Finelli; John C Rewcastle; Michael A S Jewett
Cryotherapy and radiofrequency ablation: pathophysiologic basis and laboratory studies.
Current opinion in urology 2003;13(3):187-91.
2003: Sanoj P Punnen; Joseph L Chin; Michael A S Jewett
Management of bacillus Calmette-Guerin (BCG) refractory superficial bladder cancer: results with intravesical BCG and Interferon combination therapy.
The Canadian journal of urology 2003;10(2):1790-5.
2003: Michael A S Jewett; Neil Fleshner; Laurence H Klotz; Robert K Nam; John Trachtenberg
Radical prostatectomy as treatment for prostate cancer.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2003;168(1):44-5.
2002: Murray D Krahn; Karen E Bremner; Jamil Asaria; Shabbir M H Alibhai; Robert K Nam; George Tomlinson; Michael A S Jewett; Padraig Warde; Gary Naglie
The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.
Urology 2002;60(2):258-63.
2002: Michael A S Jewett
Laparoscopic prostatectomy: here to stay.
The Canadian journal of urology 2002;9 Suppl 1():14-7.
2002: Ricardo A Rendon; John R Kachura; Joan Sweet; Mark R Gertner; Michael D Sherar; Michael Robinette; John Tsihlias; John Trachtenberg; Heather Sampson; Michael A S Jewett
The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy.
The Journal of urology 2002;167(4):1587-92.
2001: Ricardo A Rendon; Mark R Gertner; Michael D Sherar; Murray R Asch; John R Kachura; Joan Sweet; Michael A S Jewett
Development of a radiofrequency based thermal therapy technique in an in vivo porcine model for the treatment of small renal masses.
The Journal of urology 2001;166(1):292-8.
2001: Danny Vesprini; Robert K Nam; John Trachtenberg; Michael A S Jewett; S V Tavtigian; Marjan Emami; Minnie Ho; Ants Toi; Steven A Narod
HPC2 variants and screen-detected prostate cancer.
American journal of human genetics 2001;68(4):912-7.
2001: Robert K Nam; Ants Toi; Danny Vesprini; M Ho; W Chu; S Harvie; J Sweet; John Trachtenberg; Michael A S Jewett; steven narod
V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression.
Urology 2001;57(1):199-204.
2000: Ricardo A Rendon; N Stanietzky; Tony Panzarella; Michael Robinette; Laurence H Klotz; W Thurston; Michael A S Jewett
The natural history of small renal masses.
The Journal of urology 2000;164(4):1143-7.
2000: Robert K Nam; Y Elhaji; Murray D Krahn; J Hakimi; M Ho; W Chu; J Sweet; J Trachtenberg; Michael A S Jewett; steven narod
Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
The Journal of urology 2000;164(2):567-72.
2000: Padraig Warde; Mary K Gospodarowicz; Tony Panzarella; E Chow; T Murphy; Charles Catton; Jeremy F G Sturgeon; Malcolm Moore; Michael Milosevic; Michael A S Jewett
Long term outcome and cost in the management of stage I testicular seminoma.
The Canadian journal of urology 2000;7(2):967-72; discussion 973..
2000: Robert K Nam; E P Diamandis; Ants Toi; J Trachtenberg; A Magklara; Andreas Scorilas; P A Papnastasiou; Michael A S Jewett; steven narod
Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1036-42.
2000: Robert K Nam; D A Redelmeier; P E Spiess; H A Sampson; Y Fradet; Michael A S Jewett
Comparison of molecular and conventional strategies for followup of superficial bladder cancer using decision analysis.
The Journal of urology 2000;163(3):752-7.
2000: N F Logarakis; Michael A S Jewett; J Luymes; R John D'A Honey
Variation in clinical outcome following shock wave lithotripsy.
The Journal of urology 2000;163(3):721-5.
1999: Kenneth T Pace; J L Provan; Michael A S Jewett
The urology work force in Ontario for the 21st century: feast or famine?
Canadian journal of surgery. Journal canadien de chirurgie 1999;42(3):181-9.
1999: H H Lee; Padraig Warde; Michael A S Jewett
Neoadjuvant hormonal therapy in carcinoma of the prostate.
BJU international 1999;83(4):438-48.
1999: Michael A S Jewett; Luc Valiquette; H A Sampson; J Katz; Y Fradet; D A Redelmeier
Electromotive drug administration of lidocaine as an alternative anesthesia for transurethral surgery.
The Journal of urology 1999;161(2):482-5.
1999: S Sharir; Michael A S Jewett; Jeremy F G Sturgeon; M Moore; Padraig R Warde; Charles Catton; Mary K Gospodarowicz
Progression detection of stage I nonseminomatous testis cancer on surveillance: implications for the followup protocol.
The Journal of urology 1999;161(2):472-5; discussion 475-6.
1998: Michael A S Jewett; C Bombardier; Alexander G Logan; K E Psihramis; T Wesley-James; J E Mahoney; J J Luymes; Dominique Ibañez; M R Ryan; R John D'A Honey
A randomized controlled trial to assess the incidence of new onset hypertension in patients after shock wave lithotripsy for asymptomatic renal calculi.
The Journal of urology 1998;160(4):1241-3.
1998: Robert K Nam; Michael A S Jewett; Murray D Krahn
Prostate cancer: 2. Natural history.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1998;159(6):685-91.
1998: Padraig Warde; Michael A S Jewett
Surveillance for stage I testicular seminoma. Is it a good option?
The Urologic clinics of North America 1998;25(3):425-33.
1998: M K Gospodarwicz; Jeremy F G Sturgeon; Michael A S Jewett
Early stage and advanced seminoma: role of radiation therapy, surgery, and chemotherapy.
Seminars in oncology 1998;25(2):160-73.
1998: Robert K Nam; Laurence H Klotz; Michael A S Jewett; Cyril Danjoux; J Trachtenberg
Prostate specific antigen velocity as a measure of the natural history of prostate cancer: defining a 'rapid riser' subset.
British journal of urology 1998;81(1):100-4.
1997: B Ray; Michael A S Jewett; R E Donohue
Summary of distribution of retroperitoneal lymph node metastases in testicular germinal tumors (by Biswamay Ray, MD, Steven I. Hajdu, MD, and Willet F. Whitmore, Jr, MD). 1974.
Seminars in urologic oncology 1997;15(2):130-5.
1997: Padraig Warde; Mary K Gospodarowicz; D Banerjee; Tony Panzarella; Linda Sugar; Charles Catton; Jeremy F G Sturgeon; Malcolm Moore; Michael A S Jewett
Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
The Journal of urology 1997;157(5):1705-9; discussion 1709-10.